Oleandomycin

Oleandomycin is a macrolide antibiotic produced by Streptomyces antibioticus and possesses a 14-membered lactone ring structure similar to erythromycin, though it is less potent than erythromycin in clinical and microbiological uses. It was historically used under trade names including Sigmamycine, often in combination with tetracycline, for treating infections caused by Staphylococcus, Streptococcus, Corynebacterium, Neisseria, and Mycoplasma species. Presently, its primary application is in veterinary medicine, particularly for swine and poultry, with approval for such uses in several countries, including the United States. It is grouped under the following drug class(es): Macrolides. Its therapeutic use is listed as antibacterials. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include Amimycin, Landomycin, Romicil and Matromycin. Its PubChem CID is 72493.

CAS No 3922-90-5
Molecular Formula C35H61NO12
Molecular Weight 687.9 g/mol
Synonyms (3R,5S,6S,7R,8S,9R,12R,13R,14S,15R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-8-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-1,11-dioxaspiro[2.13]hexadecane-10,16-dione

Frequently Asked Questions